PVI
AUPH icon

Pura Vida Investments’s Aurinia Pharmaceuticals AUPH Stock Holding History

Pura Vida Investments’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-143,000
Closed -$1.77M – 211
2022
Q1 		$1.77M Buy
143,000
+900
+0.6% +$13.9K 0.06% 164
2021
Q4 		$3.25M Sell
142,100
-57,900
-29% -$1.37M 0.12% 130
2021
Q3 		$4.43M Buy
+200,000
New +$3.17M 0.13% 153

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Pura Vida Investments's AUPH Position: Q2 2021 in Review

Pura Vida Investments sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2021, closing a stake of 50,575 shares — an estimated $657K sold.

Pura Vida Investments first reported a position in AUPH in Q4 2019 and held it in 4 quarters. The position peaked at $5.41M in Q4 2019. 167 funds tracked by Wall St. Rank hold AUPH as of Q2 2021.

  • Pura Vida Investments reported no remaining Aurinia Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Pura Vida Investments sold 50,575 Aurinia Pharmaceuticals shares in Q2 2021, an estimated $657K.
  • Pura Vida Investments first reported a position in Aurinia Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • Pura Vida Investments's Aurinia Pharmaceuticals position peaked at $5.41M in Q4 2019.
  • 167 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.